|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.700 USD | -1.73% |
|
-1.73% | -9.57% |
| 06-15 | Waldencast plc Announces Fda Approval of Obagi Saypha Chiq Injectable Hyaluronic Acid Gel | CI |
| 06-15 | Waldencast Says US FDA Approves Obagi Saypha ChIQ Injectable Hyaluronic Acid Gel | MT |
| Market Cap | 205M 179M 166M 152M 288M 19.73B 292M 1.98B 776M 9.64B 768M 751M 33.24B | P/E 2026 * |
-2.43x | P/E 2027 * | -2.6x |
|---|---|---|---|---|---|
| Enterprise Value | 313M 274M 254M 233M 441M 30.18B 447M 3.03B 1.19B 14.75B 1.18B 1.15B 50.85B | EV / Sales 2026 * |
1.09x | EV / Sales 2027 * | 0.99x |
| Free-Float |
46.06% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.73% | ||
| 1 week | -1.73% | ||
| Current month | -3.41% | ||
| 1 month | +2.41% | ||
| 3 months | +63.46% | ||
| 6 months | +3.66% | ||
| Current year | -9.57% |
| 1 week | 1.65 |  | 1.82 |
| 1 month | 1.45 | | 1.85 |
| Current year | 0.72 | | 2.01 |
| 1 year | 0.72 | | 3.22 |
| 3 years | 0.72 | | 12 |
| 5 years | 0.72 | | 12.1 |
| 10 years | 0.72 | | 12.1 |
| Manager | Title | Age | Since |
|---|---|---|---|
Hind Sebti
COO | Chief Operating Officer | 47 | 2020-12-07 |
Michel Brousset
CEO | Chief Executive Officer | 53 | 2020-12-07 |
Manual Manfredi
DFI | Director of Finance/CFO | 50 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Michel Brousset
BRD | Director/Board Member | 53 | 2020-12-07 |
| Chairman | 60 | 2020-12-31 | |
Hind Sebti
BRD | Director/Board Member | 47 | 2024-09-25 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 3/18/26 | Zeno Equity Partners LLP
| Other | Company | 17,145,347 | 14.5273% | |
| 3/18/26 | Other | Chief Financial Officer | 118,933 | 0.1008% | ||
| 3/18/26 | Other | Director | 76,180 | 0.0645% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.73% | -1.73% | -26.09% | -73.48% | 205M | |
| -0.42% | +0.71% | +44.02% | +50.00% | 34.59B | |
| +1.77% | +4.02% | -1.06% | +3.58% | 20.62B | |
| +0.60% | +0.42% | +4.79% | - | 10.79B | |
| -1.72% | +0.89% | -35.46% | -43.03% | 4.21B | |
| +3.48% | +8.59% | -44.19% | - | 3.32B | |
| -0.65% | -15.14% | +24.69% | +21.26% | 2.02B | |
| -2.01% | -3.08% | +59.73% | - | 1.58B | |
| -1.08% | +2.86% | -23.48% | - | 1.03B | |
| 0.00% | -0.56% | - | - | 506M | |
| Average | -0.18% | +0.02% | +0.33% | -8.33% | 7.89B | |
| Weighted average by Cap. | +0.34% | +1.25% | +17.50% | +26.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 286M 251M 232M 213M 403M 27.57B 409M 2.77B 1.08B 13.48B 1.07B 1.05B 46.45B | 315M 276M 255M 234M 443M 30.36B 450M 3.04B 1.19B 14.84B 1.18B 1.16B 51.15B |
| Net income | -81.16M -71.12M -65.76M -60.46M -114M -7.83B -116M -785M -308M -3.83B -305M -298M -13.19B | -76.15M -66.73M -61.7M -56.72M -107M -7.34B -109M -737M -289M -3.59B -286M -280M -12.37B |
| Net Debt | 108M 94.99M 87.83M 80.75M 153M 10.45B 155M 1.05B 411M 5.11B 407M 398M 17.61B | 107M 94.03M 86.94M 79.93M 151M 10.35B 153M 1.04B 407M 5.06B 403M 394M 17.43B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-20 | US$1.700 | -1.73% | 209,052 |
| 26-07-17 | US$1.730 | +2.37% | 235,658 |
| 26-07-16 | US$1.690 | -1.17% | 260,704 |
| 26-07-15 | US$1.710 | -4.47% | 288,759 |
| 26-07-14 | US$1.790 | +7.19% | 541,548 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- WALD Stock
Select your edition
All financial news and data tailored to specific country editions
